Moffat L E, Sunderland G T, Lamont D
Department of Urology, Royal Infirmary, Aberdeen.
Br J Urol. 1987 Oct;60(4):316-9. doi: 10.1111/j.1464-410x.1987.tb04975.x.
Blood transfusion has been reported adversely to affect survival following surgery for a number of malignancies. We have examined retrospectively the records of 126 patients undergoing nephrectomy for renal carcinoma and established that 80 (63%) were transfused. Comparison of the two groups of patients, after controlling for differences in age, sex, tumour stage and haemoglobin level, showed that the transfused patients did not necessarily have poorer survival. In this study, peri-operative transfusion did not appear to have an adverse effect on long-term survival following surgery for renal cancer.
据报道，输血对一些恶性肿瘤手术后的生存率有不良影响。我们回顾性研究了126例行肾癌肾切除术患者的记录，确定其中80例（63%）接受了输血。在控制了年龄、性别、肿瘤分期和血红蛋白水平的差异后，对两组患者进行比较，结果显示接受输血的患者生存率不一定更低。在本研究中，围手术期输血似乎对肾癌手术后的长期生存没有不良影响。
